Showing results (771-780 of 843) with videos related to

Sort By:
Pageof 85
Nature Communications|June 9, 2017
Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challengeTodd Bradley, Justin Pollara, Sampa Santra, et al.
Cell Reports|March 2, 2017
Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman PrimatesKevin O Saunders, Nathan I Nicely, Kevin Wiehe, et al.
AIDS Research and Human Retroviruses|October 6, 2012
The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120Nicos Karasavvas, Erik Billings, Mangala Rao, et al.
Nature|February 3, 2017
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccinationNorbert Pardi, Michael J Hogan, Rebecca S Pelc, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Shared Maturation Pathways of HIV-1 Envelope-reactive V3-glycan bnAb Lineages in Human and Rhesus MacaqueMatthew Clark, Hui Li, Mitchell Martin, et al.
Science Translational Medicine|July 8, 2026
Humans and rhesus macaques share maturation pathways of HIV-1 envelope-reactive V3-glycan bnAb lineagesMatthew Clark, Hui Li, Mitchell Martin, et al.
Nature Communications|November 30, 2023
Engineered immunogens to elicit antibodies against conserved coronavirus epitopesA Brenda Kapingidza, Daniel J Marston, Caitlin Harris, et al.
Journal of Virology|April 26, 2013
Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen designLi-Hua Ping, Sarah B Joseph, Jeffrey A Anderson, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
Engineered Immunogens to Elicit Antibodies Against Conserved Coronavirus EpitopesBrenda Kapingidza, Daniel J Marston, Caitlin Harris, et al.
Cell Reports|June 14, 2025
Transient glycan shield reduction induces CD4-binding site broadly neutralizing antibodies in SHIV-infected macaquesDaniel J Morris, Jason Gorman, Tongqing Zhou, et al.
Pageof 85